Screening potential inhibitors for cancer target LSD1 from natural products by steered molecular dynamics
LSD1 is one of the important proteins which help transcriptional machine to access to DNA though open or close DNA around histone. It can also demethylate p53 at specific lysines altering the p53-mediated transcriptional process which could lead to the inhibition of the role of p53 in promoting apoptosis. Thus, inhibition of LSD1 activity by small compounds becomes a promising cancer therapy. Combining the Lipinski’s rule with docking and steered molecular dynamics simulation we have found from the traditional Chinese medicine database four compounds that are good candidates for inhibiting LSD1 activity.
Publisher URL: http://www.tandfonline.com/doi/full/10.1080/08927022.2017.1380802
DOI: 10.1080/08927022.2017.1380802
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.